The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
The myotonic dystrophies: diagnosis and management
Open accessAbstract
There are currently two clinically and molecularly defined forms of myotonic dystrophy: (1) myotonic dystrophy type 1 (DM1), also known as 'Steinert's disease'; and (2) myotonic dystrophy type 2 (DM2), also known as proximal myotonic myopathy. DM1 and DM2 are progressive multisystem genetic disorders with several clinical and genetic features in common. DM1 is the most common form of adult onset muscular dystrophy whereas DM2 tends to have a milder phenotype with later onset of symptoms and is rarer than DM1. This review will focus on the clinical features, diagnosis and management of DM1 and DM2 and will briefly discuss the recent advances in the understanding of the molecular pathogenesis of these diseases with particular reference to new treatments using gene therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brook, J. D., McCurrach, M. E., Harley, H. G., Buckler, A. J., Church, D., Aburatani, H., Hunter, K., Stanton, V. P., Thirion, J.-P., Hudson, T., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90154-5 · Cited by 2,777
Pochet, P. (2006) · Griffith Research Online · Cited by 1,550
Myotonic Dystrophy Type 2 Caused by a CCTG Expansion in Intron 1 of ZNF9
Liquori, C. L., Ricker, K., Moseley, M. L., Jacobsen, J. F., Kress, W., Naylor, S. L., Day, J. W., & Ranum, L. P. W. (2001) · Science · doi:10.1126/science.1062125 · Cited by 1,231
Harper, P. S. (2001) · Cited by 908
Savkur, R. S., Philips, A. V., & Cooper, T. A. (2001) · Nature Genetics · doi:10.1038/ng704 · Cited by 795
Diseases of Unstable Repeat Expansion: Mechanisms and Common Principles
Gatchel, J. R., & Zoghbi, H. Y. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1691 · Cited by 794
A Muscleblind Knockout Model for Myotonic Dystrophy
Kanadia, R. N., Johnstone, K. A., Mankodi, A., Lungu, C., Thornton, C. A., Esson, D., Timmers, A. M., Hauswirth, W. W., & Swanson, M. S. (2003) · Science · doi:10.1126/science.1088583 · Cited by 743
Mankodi, A., Takahashi, M. P., Jiang, H., Beck, C. L., Bowers, W. J., Moxley, R. T., Cannon, S. C., & Thornton, C. A. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00563-4 · Cited by 672
Electrocardiographic Abnormalities and Sudden Death in Myotonic Dystrophy Type 1
Groh, W. J., Groh, M. R., Saha, C., Kincaid, J. C., Simmons, Z., Ciafaloni, E., Pourmand, R., Otten, R. F., Bhakta, D., Nair, G. V., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa062800 · Cited by 511
Myotonic dystrophy type 2: Molecular, diagnostic and clinical spectrum
Day, J. W., Ricker, K., Jacobsen, J. F., Rasmussen, L. J., Dick, K. A., Kress, W., Schneider, C., Koch, M. C., Beilman, G. J., Harrison, A. R., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000054481.84978.f9 · Cited by 467
A 10-year study of mortality in a cohort of patients with myotonic dystrophy
Mathieu, J., Allard, P., Potvin, L., Prévost, C., & Bégin, P. (1999) · Neurology · doi:10.1212/wnl.52.8.1658 · Cited by 414
Kanadia, R. N., Shin, J., Yuan, Y., Beattie, S. G., Wheeler, T. M., Thornton, C. A., & Swanson, M. S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604970103 · Cited by 371
Strength training and aerobic exercise training for muscle disease
Voet, N. B., van der Kooi, E. L., Riphagen, I. I., Lindeman, E., van Engelen, B. G., & Geurts, A. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003907.pub4 · Cited by 327
Age and causes of death in adult-onset myotonic dystrophy
de Die-Smulders, C. (1998) · Brain · doi:10.1093/brain/121.8.1557 · Cited by 266
Clinical and molecular aspects of the myotonic dystrophies: A review
Machuca‐Tzili, L., Brook, D., & Hilton‐Jones, D. (2005) · Muscle & Nerve · doi:10.1002/mus.20301 · Cited by 260
Self-citationWheeler, T. M., Lueck, J. D., Swanson, M. S., Dirksen, R. T., & Thornton, C. A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33355 · Cited by 256
Lindeman, E., Leffers, P., Spaans, F., Drukker, J., Reulen, J., Kerckhoffs, M., & Köke, A. (1995) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/s0003-9993(95)80629-6 · Cited by 239
Lavedan, C. N., Hofmann-Radvanyi, H., Shelbourne, P., Rabès, J., Duros, C., Savoy, D., Dehaupas, I., Luce, S., Johnson, K. J., & Junien, C. (1993) · Europe PMC (PubMed Central) · Cited by 235
New nomenclature and DNA testing guidelines for myotonic dystrophy type 1 (DM1)
The International Myotonic Dystrophy Consortium (IDMC) (2000) · Neurology · doi:10.1212/wnl.54.6.1218 · Cited by 234
Myotonic Dystrophy: RNA Pathogenesis Comes into Focus
Ranum, L. P. W., & Day, J. W. (2004) · The American Journal of Human Genetics · doi:10.1086/383590 · Cited by 228
Cardiac disease in myotonic dystrophy
Phillips, M. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(96)00163-0 · Cited by 216
Redman, J. B. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500150072029 · Cited by 210
RNA pathogenesis of the myotonic dystrophies
Day, J. W., & Ranum, L. P. W. (2005) · Neuromuscular Disorders · doi:10.1016/j.nmd.2004.09.012 · Cited by 192
Reversible model of RNA toxicity and cardiac conduction defects in myotonic dystrophy
Mahadevan, M. S., Yadava, R. S., Yu, Q., Balijepalli, S., Frenzel-McCardell, C. D., Bourne, T. D., & Phillips, L. H. (2006) · Nature Genetics · doi:10.1038/ng1857 · Cited by 185
Characterization of the Pattern of Cognitive Impairment in Myotonic Dystrophy Type 1
Modoni, A., Silvestri, G., Grazia Pomponi, M., Mangiola, F., Tonali, P. A., & Marra, C. (2004) · Archives of Neurology · doi:10.1001/archneur.61.12.1943 · Cited by 171
Creatine for treating muscle disorders
Kley, R. A., Tarnopolsky, M. A., & Vorgerd, M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004760.pub4 · Cited by 169
Anesthetic and surgical complications in 219 cases of myotonic dystrophy
Mathieu, J., Allard, P., Gobeil, G., Girard, M., De Braekeleer, M., & Bégin, P. (1997) · Neurology · doi:10.1212/wnl.49.6.1646 · Cited by 164
Apathy and hypersomnia are common features of myotonic dystrophy
Rubinsztein, J. S., Rubinsztein, D. C., Goodburn, S. F., & Holland, A. J. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.4.510 · Cited by 153
Trip, J., Drost, G., van Engelen, B. G. M., & Faber, C. G. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004762.pub2 · Cited by 140
Modafinil reduces excessive somnolence and enhances mood in patients with myotonic dystrophy
MacDonald, J. R., Hill, J. D., & Tarnopolsky, M. A. (2002) · Neurology · doi:10.1212/01.wnl.0000037481.08283.51 · Cited by 131
Lazarus, A., Varin, J., Ounnoughene, Z., Radvanyi, H., Junien, C., Coste, J., Laforêt, P., Eymard, B., Bécane, H. M., Weber, S., et al. (1999) · Circulation · doi:10.1161/01.cir.99.8.1041 · Cited by 127
Antonini, G., Soscia, F., Giubilei, F., Carolis, A. D., Gragnani, F., Morino, S., Ruberto, A., & Tatarelli, R. (2006) · Journal of Rehabilitation Medicine · doi:10.1080/16501970500477967 · Cited by 120
Severe cardiac arrhythmias in young patients with myotonic dystrophy type 1
Bassez, G., Lazarus, A., Desguerre, I., Varin, J., Laforêt, P., Bécane, H. M., Meune, C., Arné‐Bes, M., Ounnoughene, Z., Radvanyi, H., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000144343.91136.cf · Cited by 111
Brunner, H. G., Brüggenwirth, H. T., Nillesen, W., Jansen, G., Hamel, B. C. J., Hoppe, R. L. E., de Die-Smulders, C. E. M., Höweler, C., van Oost, B. A., & Wieringa, B. (1993) · PubMed · Cited by 108
Udd, B., Meola, G., Krahe, R., Thornton, C. A., Ranum, L. P. W., Bassez, G., Kress, W., Schoser, B. G. H., & Moxley, R. T. (2006) · Neuromuscular Disorders · doi:10.1016/j.nmd.2006.03.010 · Cited by 107
Personality Patterns in Patients With Myotonic Dystrophy
Delaporte, C. (1998) · Archives of Neurology · doi:10.1001/archneur.55.5.635 · Cited by 106
Modafinil for excessive daytime sleepiness in myotonic dystrophy
Damian, M., Gerlach, A., Schmidt, F., Lehmann, E., & Reichmann, H. (2001) · Neurology · doi:10.1212/wnl.56.6.794 · Cited by 105
Hammerhead ribozyme-mediated destruction of nuclear foci in myotonic dystrophy myoblasts
Langlois, M., Lee, N. S., Rossi, J. J., & Puymirat, J. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00068-6 · Cited by 104
Temperament and character in patients with classical myotonic dystrophy type 1 (DM-1)
Winblad, S., Lindberg, C., & Hansen, S. (2005) · Neuromuscular Disorders · doi:10.1016/j.nmd.2004.12.003 · Cited by 100
Myotonic dystrophy: present management, future therapy
(2004) · doi:10.1093/oso/9780198527824.001.0001 · Cited by 97
Similar brain tau pathology in DM2/PROMM and DM1/Steinert disease
Maurage, C., Udd, B., Ruchoux, M., Vermersch, P., Kalimo, H., Krahe, R., Delacourte, A., & Sergeant, N. (2005) · Neurology · doi:10.1212/01.wnl.0000184585.93864.4e · Cited by 94
Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy
Talbot, K., Stradling, J. R., Crosby, J., & Hilton‐Jones, D. (2003) · Neuromuscular Disorders · doi:10.1016/s0960-8966(03)00030-0 · Cited by 91
Self-citationFrequency and stability of the myotonic dystrophy type 1 premutation
Martorell, L., Monckton, D. G., Sánchez, A., de Munaín, A. L., & Baiget, M. (2001) · Neurology · doi:10.1212/wnl.56.3.328 · Cited by 88
Gastrointestinal Symptoms in Myotonic Dystrophy
Rönnblom, A., Forsberg, H., & Danielsson, A. (1996) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529609009145 · Cited by 86
Myotonic dystrophy: will the real gene pleasestep forward!
Harris, S. E., Moncrieff, C. L., & Johnson, K. J. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.supplement_1.1417 · Cited by 84
Insulin-like Growth Factor Isoforms in Skeletal Muscle Aging, Regeneration, and Disease
Winn, N., Paul, A. C., Musarò, A., & Rosenthal, N. A. (2002) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2002.67.507 · Cited by 83
Viral vector producing antisense RNA restores myotonic dystrophy myoblast functions
Furling, D., Doucet, G., Langlois, M., Timchenko, L., Belanger, E., Cossette, L. J., & Puymirat, J. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301955 · Cited by 81
Temmerman, N. D., Sermon, K., Seneca, S., Rycke, M. D., Hilven, P., Lissens, W., Steirteghem, A. V., & Liebaers, I. (2004) · The American Journal of Human Genetics · doi:10.1086/422762 · Cited by 79
Steyaert, J. G., Umans, S., Willekens, D., Legius, E., Pijkels, E., de Die-Smulders, C. E. M., BERGHE, H. V. D., & Fryns, J. (1997) · Clinical Genetics · doi:10.1111/j.1399-0004.1997.tb02533.x · Cited by 77
Anatomy of a founder effect: myotonic dystrophy in Northeastern Quebec
Yotova, V., Labuda, D., Ziętkiewicz, E., Gehl, D., Lovell, A. D., Lefebvre, J.-F., Bourgeois, S., Lemieux‐Blanchard, É., Labuda, M., Vézina, H., et al. (2005) · Human Genetics · doi:10.1007/s00439-005-1298-8 · Cited by 69
Excessive daytime sleepiness in myotonic dystrophy
Giubilei, F., Antonini, G., Bastianello, S., Morino, S., Paolillo, A., Fiorelli, M., Ferretti, C., & Fieschi, C. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00042-8 · Cited by 65
Pilomatricoma in childhood: a retrospective study from three European paediatric centres
Cigliano, B., Baltogiannis, N., Marco, M. D., Faviou, E., Settimi, A., Tilemis, S., Soutis, M., Papandreou, E., D'Agostino, S., & Fabbro, M. A. (2005) · European Journal of Pediatrics · doi:10.1007/s00431-005-1730-z · Cited by 64
Genotype ‐phenotype correlation in myotonic dystrophy
Gharehbaghi-Schnell, E., Finsterer, J., Korschineck, I., Mamoli, B., & Binder, B. R. (1998) · Clinical Genetics · doi:10.1111/j.1399-0004.1998.tb02576.x · Cited by 62
Tarnopolsky, M., Mahoney, D., Thompson, T., Naylor, H., & Doherty, T. J. (2004) · Muscle & Nerve · doi:10.1002/mus.10527 · Cited by 54
Creatine monohydrate in myotonic dystrophy
Walter, M. C., Reilich, P., Lochm�ller, H., Kohnen, R., Schlotter, B., Hautmann, H., Dunkl, E., Pongratz, D., & M�ller-Felber, W. (2002) · Journal of Neurology · doi:10.1007/s00415-002-0923-x · Cited by 53
Strength training and aerobic exercise training for muscle disease
Voet, N. B. M., van der Kooi, E. L., Riphagen, I. I., Lindeman, E., van Engelen, B. G. M., & Geurts, A. C. H. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003907.pub3 · Cited by 53
Oyamada, R., Hayashi, M., Katoh, Y., Tsuchiya, K., Mizutani, T., Tominaga, I., & Kashima, H. (2006) · Neuropathology · doi:10.1111/j.1440-1789.2006.00662.x · Cited by 50
Moxley, R. T., Ricker, K., Chad, D. A., Lacomis, D., Skare, J. C., Smith, T. W., Martínez, A. C., Arpa, J., Martínez, N., Iváñez, V., et al. (1995) · Muscle & Nerve · doi:10.1002/mus.880180516 · Cited by 49
A pilot study of dehydroepiandrosterone sulfate in myotonic dystrophy.
Sugino, M., Ohsawa, N., Ito, T., Ishida, S., Yamasaki, H., Kimura, F., & Shinoda, K. (1998) · Neurology · doi:10.1212/wnl.51.2.586 · Cited by 49
Wintzen, A. R., Lammers, G. J., & van Dijk, J. G. (2007) · Journal of Neurology · doi:10.1007/s00415-006-0186-z · Cited by 46
Creatine for treating muscle disorders
Kley, R. A., Vorgerd, M., & Tarnopolsky, M. A. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004760.pub2 · Cited by 45
Gastric emptying in myotonic dystrophy
Rönnblom, A., Andersson, S., Hellström, P. M., & Danielsson, A. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.01028.x · Cited by 44
Axonal function and activity‐dependent excitability changes in myotonic dystrophy
Krishnan, A. V., & Kiernan, M. C. (2006) · Muscle & Nerve · doi:10.1002/mus.20516 · Cited by 41
Furling, D., Marette, A., & Puymirat, J. (1999) · Endocrinology · doi:10.1210/endo.140.9.7057 · Cited by 39
Nutritional inadequacy in adults with muscular dystrophy
Motlagh, B., MacDonald, J. R., & Tarnopolsky, M. A. (2005) · Muscle & Nerve · doi:10.1002/mus.20317 · Cited by 35
Creatine monohydrate in DM2/PROMM: a double-blind placebo-controlled clinical study
Schneider–Gold, C., Beck, M., Wessig, C., George, A., Kele, H., Reiners, K., & Toyka, K. V. (2003) · Neurology · doi:10.1212/01.wnl.0000044405.29988.e1 · Cited by 35
Drug treatment for myotonia (Review)
Trip, J., Drost, G., van Engelen, B. G. M., et al. (2006) · Cochrane Database of Systematic Reviews · Cited by 35
Reduced Adrenal Androgens in Patients with Myotonic Dystrophy
CARTER, J. N., & Steinbeck, K. S. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-3-611 · Cited by 31
Transmission ratio distortion in the myotonic dystrophy locus in human preimplantation embryos
Dean, N. L., Loredo-Osti, J. C., Fujiwara, T. M., Morgan, K., Tan, S. L., Naumova, A. K., & Ao, A. (2006) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201559 · Cited by 29
A Reversal of Misfortune for Myotonic Dystrophy?
Cooper, T. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmcibr064708 · Cited by 24
Cited by
Prevalence of Muscular Dystrophies: A Systematic Literature Review
Theadom, A., Rodrigues, M., Roxburgh, R., Balalla, S., Higgins, C., Bhattacharjee, R., Jones, K., Krishnamurthi, R., & Feigin, V. (2014) · Neuroepidemiology · doi:10.1159/000369343 · Cited by 2,046
How Persons with a Neuromuscular Disease Perceive Employment Participation: A Qualitative Study
Minis, M.-A. H., Satink, T., Kinébanian, A., Engels, J. A., Heerkens, Y. F., van Engelen, B. G. M., & Nijhuis-van der Sanden, M. W. G. (2014) · Journal of Occupational Rehabilitation · doi:10.1007/s10926-013-9447-8 · Cited by 22
Matsumoto, A. M., & Bremner, W. J. (2011) · Williams Textbook of Endocrinology · doi:10.1016/b978-1-4377-0324-5.00019-5 · Cited by 18
Metadata
- Authors
- Turner, C., & Hilton-Jones, D.
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 2010-02-22
- Volume
- 81
- Issue
- 4
- Pages
- 358-367
- ISSN
- 0022-3050 (ISSN-L)
- OpenAlex
- W2137371531
- Cited by
- 329
- References
- 71
- FWCI
- 8.20
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.